Just a moment, the page is loading...

GSK-113617




Gynaecological Follow-up of a Subset of HPV-015 Study Subjects
Human Papillomavirus Types 16 and 18 Vaccine
113617
NCT01190176 2009-017282-35
Infections, Papillomavirus
Phase 3
This is a follow-up study to 104820.
April 2019